Results 131 to 140 of about 27,891 (280)
Montelukast and Churg-Strauss syndrome
The association of leukotriene receptor antagonists and Churg-Strauss Syndrome (CSS) has been recognised for several years. However, whether these drugs have a direct pathogenic role remains controversial. The present case describes an asthmatic patient, who developed severe obstructive symptoms and progressive heart failure after two sequential ...
David, Conen+5 more
openaire +3 more sources
Treating asthma: is there a place for leukotriene receptor antagonists? [PDF]
SummaryAsthma is a chronic disorder, characterized by airway hyperresponsiveness (AHR), airway inflammation and airway remodelling. Evidence has been provided for a relationship between pathophysiology, airway inflammation and remodelling.
Björn Sarrazin+8 more
core +3 more sources
Attenuation of acute systemic inflammatory response after valve surgery
Objective This study highlights the protective effects of montelukast on myocardial ischemic reperfusion injury induced by cardiopulmonary bypass during valve replacement surgery.
Najah R. Hadi+8 more
doaj
The complex pathogenesis of cyclophosphamide-induced hemorrhagic cystitis involves arachidonic acid-derived inflammatory mediators, among them leukotrienes. Montelukast, a leukotriene receptor antagonist, is reported to exert an alleviatory effect in the
Dobrek Lukasz+3 more
doaj +1 more source
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Altman+74 more
core +1 more source
Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist [PDF]
Theodore F. Reiss+7 more
openalex +1 more source
Background: Secretion of nasal discharge was enhanced and airway-resistance in the nasal cavity was augmented, resulting in nasal congestion, when leukotrienes were administered to the nasal mucosa.
Kimihiro Okubo, Kohtaro Baba
doaj +1 more source
Churg-Strauss syndrome associated with montelukast therapy [PDF]
J M Tuggey
openalex +1 more source